Riedl et al. evaluated the positive efficacy of a topical gel containing liposomal encapsulated recombinant human SOD in the treatment of Peyronie’s Disease, a painful fibroproliferative disorder of the penis which is pathophysiologically comparable to DD [30]. Here, SOD1 is linked to Abnormality of connective tissue.